-+ 0.00%
-+ 0.00%
-+ 0.00%

ROYALTY PHARMA : FULL YEAR 2026 GUIDANCE: PORTFOLIO RECEIPTS EXPECTED TO BE $3,500 MLN TO $3,550 MLN

Reuters·11/04/2026 12:15:37